San Francisco Bay Area biotech stories.
Monday, September 24, 2012
Nodality picks Laura Brege as new president, CEO
New Nodality President and CEO Laura Brege.
Diagnostic test developer Nodality Inc. hired former Onyx Pharmaceuticals COO Laura Brege as its new president and CEO.
The South San Francisco company, whose technology helps to show a drug maker why a drug does or does not work, said Brege led commercialization, strategic planning, corporate development and medical, scientific and government affairs at Onyx (NASDAQ: ONXX). She retired from South San Francisco-based Onyx at the end of last year.
Share to Twitter
Share to Facebook
Share to Pinterest
Post a Comment
Post Comments (Atom)